Literature DB >> 9184722

Risks of infection or reactivation of tuberculosis associated with chronic corticosteroid therapy.

J C Cline1, S M Davis.   

Abstract

Although corticosteroids are known to be immunosuppressive, there have been no studies to show that use of corticosteroids increases the risk of developing new tuberculosis or reactivating old tuberculosis. In fact, corticosteroids are recommended for the treatment of several forms of tuberculosis, such as pleural tuberculosis, genitourinary tuberculosis, and tuberculous meningitis. Clinicians should still be alert for tuberculosis appearing in immunocompromised patients as a disseminated infection or for tuberculosis that is atypical in appearance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184722

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  3 in total

1.  Awareness of the adverse effects associated with prophylactic corticosteroid use during docetaxel therapy.

Authors:  Ka-Eun Yoo; Rae Young Kang; Ju-Yeun Lee; Yu Jeung Lee; Sung Yun Suh; Kwi Suk Kim; Hyang Sook Kim; Se-Hoon Lee; Byung Koo Lee
Journal:  Support Care Cancer       Date:  2014-12-13       Impact factor: 3.603

2.  Effect of Concomitant Tuberculosis Infection on COVID-19 Disease in Children: A Matched, Retrospective Cohort Study.

Authors:  Surendra Bahadur Mathur; Romit Saxena; Pallavi Pallavi; Rahul Jain; Devendra Mishra; Urmila Jhamb
Journal:  J Trop Pediatr       Date:  2022-06-06       Impact factor: 1.794

3.  Effects of ascent to high altitude on human antimycobacterial immunity.

Authors:  Sarah Eisen; Louise Pealing; Robert W Aldridge; Mark J Siedner; Alejandro Necochea; Inna Leybell; Teresa Valencia; Beatriz Herrera; Siouxsie Wiles; Jon S Friedland; Robert H Gilman; Carlton A Evans
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.